Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-11-03 00:00:00 ET · period of report 2022-11-02 · accession 0001415889-22-011066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-03 | 2022-11-02 | JBIO | Verwijs Marinus | SVP, CMC | S - Sale | $18.89 | -1,130 | 0 | -100% | -$21.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-02 | S | D | 1,130 | $18.89 | 0 | D | — | — | (F2) Includes 1,130 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d). |